Skin Wound
Of the 2 unique stories with a clear outcome, 1 reported it helped (50%).
These are public YouTube testimonials, not clinical evidence. People who tried BPC-157 and got no result rarely post videos — read this as a sample of the positive end of the distribution.
“heal dramatically faster”
“wound closed really fast but sealed in an infection”
Related research
Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats.
BPC-157 therapy was shown to rapidly reverse tracheocutaneous fistula in rats by acting through the NO system, leading to healing of skin and tracheal defects and fistula closure. The therapy also counteracted the negative effects of NO system blockade and immobilization.
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.
This review concludes that BPC-157 has pleiotropic beneficial effects, controlling and modulating angiogenesis and the NO-system, and shows promise in wound healing and counteracting neurodegenerative diseases. BPC-157 also exhibits anti-tumor potential and does not produce corneal neovascularization.
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.
This study found that BPC-157 has a short elimination half-life and is rapidly metabolized into small peptide fragments in rats and dogs. The results provide the first analysis of the pharmacokinetics of BPC-157, which will be helpful for its translation in the clinic.
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.
This review concludes that BPC-157 has potential in wound healing, including skin wounds, burns, and ulcers, by promoting resolution of vessel constriction and clotting. The peptide may also have applications in healing other tissues, including the gastrointestinal tract and blood vessels.